Search clinical trials for: exenatide extended-release

Total 6494 results

Universitätsklinikum Hamburg-Eppendorf
Olympus Deutschland GmbH

Completed

How Effective Can a Simulator-Based Training Course For Beginners In Endoscopy Be Made? (EFFEKTRA)

Physicians Gastroscopy Training

Germany
University of Oregon

Completed

Sleep and Girls' Emotions Study (SAGE)

Depression

United States
Daniel A. Siniawski
Merck Sharp & Dohme LLC

Terminated

Lipid Efficacy of the Extended Release Niacin/Laropiprant Combination in Patients With Cardiovascular Disease

Coronary Artery Disease | Dyslipidemias

Argentina
Yale University
National Institute on Drug Abuse (NIDA); Baystate Medical Center

Completed

Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations (NewHope)

HIV | Opioid Dependence | AIDS | Drug Dependence

United States
Novo Nordisk A/S

Completed

The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy (DUAL™ III)

Diabetes Mellitus, Type 2 | Diabetes

United States, Slovakia, Hungary, France, Australia
Wu Qinan

Unknown

Study of Comparison the Treatment Effect Between Gastric Bypass and Exenatide in Type 2 Diabetes

Type 2 Diabetes

China
Xinrui Zhu，MD

Not yet recruiting

Extended Pancreatic Transection Versus Conventional Pancreatic Transection During Laparoscopic Pancreaticoduodenectomy

Laparoscopic Pancreaticoduodenectomy
Chung-Ang University
National Research Foundation of Korea

Completed

Effects of Daily Eating Duration on Health

Nutritional and Metabolic Diseases | Body Weight Maintenance

Korea, Republic of
Maastricht University Medical Center
RWTH Aachen University

Unknown

Atrial Fibrillation Ablation Registry (AFAB)

Atrial Fibrillation (Paroxysmal) | Atrial Fibrillation Recurrent | Atrial Fibrillation Common Gene Variants

Netherlands
Meshalkin Research Institute of Pathology of Circulation

Unknown

Comparisonof Extended Myoectomy and Myoectomy by Morrow in Patients With Hypertrophic Obstructive Cardiomyopathy (HOCM)

Hypertrophic Obstructive Cardiomyopathy

Russian Federation
Yonsei University

Unknown

Distances From Cricoid Cartilage to the Targets of Stellate Ganglion Block

Herpes Zoster | CRPS

Korea, Republic of
GlaxoSmithKline

Completed

Out-Patient Study in Patients With Type 2 Diabetes Mellitus Who Are Taking no Diabetes Medication or Metformin Only

Diabetes Mellitus, Type 2

United States, Dominican Republic, Chile
Boehringer Ingelheim

Completed

Relative Bioavailability of Different Oral Viramune Extended Release Formulations Compared to Viramune® Oral Suspension in Healthy Male Volunteers

Healthy
University Hospital, Basel, Switzerland
Gottfried und Julia Bangerter-Rhyner-Stiftung

Completed

Exenatide-test for Diagnosing Endogenous Hyperinsulinemic Hypoglycemia (FAST)

Endogenous Hyperinsulinism

Switzerland
Thomas Jefferson University
Eli Lilly and Company; Amylin Pharmaceuticals, LLC.

Completed

Intravenous Exenatide (Byetta) During Surgery

Hyperglycemia | Hypoglycemia | Euglycemia

United States
Riphah International University

Recruiting

Effects of Myofascial Release in Cerebral Palsy Children

Cerebral Palsy

Pakistan
Riphah International University

Completed

Positional Release Technique in Patients With Unilateral Subacute Trapezitis

Cervical Spine Disease

Pakistan
Philips Clinical & Medical Affairs Global

Recruiting

Arrhythmia Identification in Syncope Patients: ePatch® Versus 24h Holter

Syncope | Arrythmia

France, Germany
Northwestern University
National Center for Complementary and Integrative Health (NCCIH)

Completed

Awareness and Self-Compassion Enhancing Narcolepsy Treatment (ASCENT)

Narcolepsy | Narcolepsy Without Cataplexy | Narcolepsy With Cataplexy

United States
Imperial College London

Unknown

Effects of Extended Haemodialysis Treatment Duration in Patients With End-stage Renal Disease

End Stage Renal Disease

United Kingdom
UConn Health

Completed

Length of Post Operative Dressing After Carpal Tunnel Release

Carpal Tunnel Syndrome

United States
GlaxoSmithKline
The General Hospital Corporation d/b/a Massachusetts General Hospital

Terminated

A Study Comparing the Effect of Albiglutide With Exenatide on Regional Brain Activity Related to Nausea in Healthy Subjects

Diabetes Mellitus

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Pharmacokinetics of Venlafaxine Extended-Release (ER) and Desvenlafaxine Succinate Sustained-Release (DVS SR) 50 mg in Healthy Subjects

Healthy

United States
Friends Research Institute, Inc.

Not yet recruiting

Buprenorphine for Individuals in Jail

Opioid Use Disorder

United States
NYU Langone Health
Winthrop University Hospital

Withdrawn

Dose Clinical Trial of Guanfacine Extended Release for the Reduction of Aggression and Self-injuries Behavior Associated With Prader-Willi Syndrome

Prader-Willi Syndrome

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Multicenter Trial of Combined Pharmacotherapy to Treat Cocaine Dependence (TACT2)

Cocaine Dependence

United States
Oregon Health and Science University
National Institute on Drug Abuse (NIDA)

Completed

Comparing Treatments for HIV-Infected Opioid and Alcohol Users in an Integrated Care Effectiveness Study (CHOICES)

Opioid Use Disorder | Alcohol Use Disorder

Canada, United States
Merck KGaA, Darmstadt, Germany

Completed

Tolerability of Rebif® (Interferon-beta 1-A) Therapy in Korean Patients With Multiple Sclerosis

Multiple Sclerosis

Korea, Republic of
Pfizer

Completed

A Study To Evaluate Different Formulations Of PF-06865571 In Healthy Subjects

Healthy

Belgium
Stanford University

Completed

Exenatide and Weight Loss for Diabetes Prevention

Insulin Resistance | Pre Diabetes
Cedars-Sinai Medical Center
Astellas Pharma Inc

Completed

Trial to Evaluate Safety and Tolerability of Tacrolimus Extended-Release (Astagraf XL) in Human Leukocyte Antigen (HLA) Sensitized Kidney Transplant Recipients

End Stage Renal Disease

United States
Shire

Completed

Safety and Efficacy of SPD476 (Mesalazine) Given Twice Daily (2.4 g/Day) vs SPD476 Given as a Single Dose (4.8 g/Day) in Subjects With Acute Mild to Moderate Ulcerative Colitis

Colitis, Ulcerative

United States
NYU Langone Health
Alkermes, Inc.; New York City Department of Health and Mental Hygiene

Completed

Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail

Opiate Dependence

United States
Hannover Medical School

Completed

The High Density Lipoprotein and Endothelial Function, Niacin and Nitric Oxide Study (The High-Ennd Study)

Metabolic Syndrome

Germany
Jiangsu HengRui Medicine Co., Ltd.
Beijing Tongren Hospital

Completed

A Phase I Study of 8-week Continuous Treatment With Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes

Type 2 Diabetes

China
Jiangsu HengRui Medicine Co., Ltd.
People's Liberation Army General Hospital of Chengdu Military Region

Completed

A Phase I Study of Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes

Type 2 Diabetes

China
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Unknown

Polyethylene Glycol Loxenatide Pharmacokinetics Study in Subjects With Normal and Insufficiency Renal Function

Type 2 Diabetes Mellitus

China
University of California, San Francisco

Completed

Micronutrient Supplementation in Children With ASD

Autism Spectrum Disorder

United States
Dokuz Eylul University

Recruiting

Effects of Myofascial Release Technique on Mobility, Sensorimotor Function and Performance in Volleyball Players

Athletes | Volleyball

Turkey
Université de Sherbrooke

Completed

Effects of a Myofascial Technique on Biomechanical Properties of the Lumbar Myofascia of Chronic Low Back Pain Adults

Chronic Low Back Pain

Canada
Weill Medical College of Cornell University

Withdrawn

Efficacy of Exenatide-LAR and Dapagliflozin in Overweight/Obese, Insulin Treated Patients With Type 2 Diabetes (Dexlar)

Diabetes Mellitus, Type 2

United States
Cliniques universitaires Saint-Luc- Université...

Completed

Effect of GLP-1 Analogs on Psoriasis in Type 2 Diabetic Patients

Psoriasis | Type 2 Diabetes

Belgium
The Affiliated Nanjing Drum Tower Hospital of Nanjing...

Completed

A Comparison of Exenatide and Insulin Glargine

Type 2 Diabetes

China
National Institute on Aging (NIA)

Terminated

A Pilot Clinical Trial of Exendin-4 in Alzheimer's Disease

Mild Cognitive Impairment | Alzheimer's Disease

United States
University of Aarhus
Innovation Fund Denmark

Recruiting

The Effect of Alginate Encapsulated Supplements on Athletic Performance and Recovery (SWAP)

Athletic Performance

Denmark
Yeditepe University

Not yet recruiting

Comparison of the Immediate Effects of Physiotherapist and Self-administered Myofascial Release Techniques on Flexibility and Jumping Ability in Basketball Players

Myofascial Spasm

Turkey
Peking University People's Hospital

Completed

Efficacy of Ultrasound-guided Transverse Carpal Ligament Release for Carpal Tunnel Syndrome

Carpal Tunnel Syndrome

China
Akdeniz University
Pamukkale University

Completed

Investigation of Acute Effects of Myofascial Trigger Point Release in Women With Chronic Pelvic Pain

Pelvic Pain | Myofascial Trigger Point Pain | Pelvic Floor; Relaxation

Turkey
Balgrist University Hospital

Completed

Neuropathy of the Suprascapular Nerve Before and After Reconstruction of the Cuff (Neurospura)

Cuff Rotator Full Thickness Tear | Cuff Rotator Syndrome

Switzerland
Maimonides Medical Center

Recruiting

Guanfacine Extended Release for the Reduction of Aggression and Self-injurious Behavior Associated With Prader-Willi Syndrome (PWS-GXR)

Aggression | Behavioral Symptoms | Pathologic Processes | Nervous System Diseases | Obesity | Neurologic Manifestations | Neurobehavioral Manifestations | Congenital Abnormalities | Overnutrition | Nutrition Disorders | Genetic Diseases, Inborn | Intellectual Disability | Self-Injurious Behavior | Abnormalities, Multiple and other conditions

United States

Search clinical trials for: exenatide extended-release

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Trinidad & Tobago

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations